醒脑开窍中药联合软通道微创血肿引流术治疗高血压脑出血的临床研究

发布时间：2018-05-11 16:11

本文选题：醒脑开窍 + 中药　；参考：《中国中医急症》2016年12期

【摘要】：目的观察醒脑开窍中药联合软通道微创血肿引流术治疗高血压脑出血的临床疗效。方法临床收集并纳入高血压脑出血患者70例,随机分入治疗组和对照组。所有患者均行定向软通道微创血肿引流术,治疗组术后第2日开始鼻饲醒脑开窍中药汤剂(干预3周)。观察两组患者术后苏醒时间、治疗前后中医症状积分、NIHSS评分、Barthel指数评分及并发症发生率。结果治疗组术后苏醒时间早于对照组(P0.05);治疗3周后,治疗组中医症状积分、NIHSS、Barthel指数评分改善均优于对照组(P0.05);治疗组和对照组并发症发生率均为2.86%,差异无统计学意义(P0.05)。结论醒脑开窍中药联合软通道微创血肿引流术治疗高血压脑出血临床疗效确切,能有效促进患者术后苏醒、改善中医症状积分、对神经功能及日常生活活动能力康复具有积极作用。
[Abstract]:Objective to observe the clinical effect of Xingnao Kaiqiao Chinese medicine combined with soft channel minimally invasive hematoma drainage for hypertensive intracerebral hemorrhage. Methods 70 patients with hypertensive intracerebral hemorrhage were randomly divided into treatment group and control group. All the patients were treated with directional soft channel minimally invasive hematoma drainage. The treatment group received nasal feeding of Xingnao Kaiqiao decoction on the 2nd day after operation (intervention for 3 weeks). The recovery time, NIHSS score, Barthel index and complication rate before and after treatment were observed. Results the postoperative recovery time in the treatment group was earlier than that in the control group (P 0.05), after 3 weeks of treatment, the improvement of NIHSS Barthel index in the treatment group was better than that in the control group (P 0.05), and the incidence of complications in the treatment group and the control group was 2.86, with no significant difference (P 0.05). Conclusion Xingnao Kaiqiao Chinese medicine combined with soft channel minimally invasive hematoma drainage is effective in the treatment of hypertensive intracerebral hemorrhage. It can effectively promote the recovery of patients after operation and improve the score of symptoms of traditional Chinese medicine. It has positive effect on the rehabilitation of nerve function and activity of daily life.
【作者单位】：上海中医药大学附属岳阳中西医结合医院;
【基金】：上海市卫生和计划生育委员会科研课题(201440321)
【分类号】：R544.1;R743.34

【相似文献】